The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy

Abstract

In lobular tumors the benefit with regard to breast-conserving surgery of neoadjuvant chemotherapy is questionable. Although in ER-positive tumors the pCR rate is low, the increase in breast-conserving surgery was remarkable in ductal ER-positive tumors.